# Aflibercept vs. Ranibizumab: cost‐effectiveness of treatment for wet age‐related macular degeneration in Sweden

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/aflibercept-vs-ranibizumab-cost-effectiveness-of-treatment-for-wet-age-related/

## Facts

| Field | Value |
| --- | --- |
| Author Names | H. Panchmatia,Karen M. Clements,Erin Hulbert,Marianne Eriksson,Kim Wittrup‐Jensen,Jonas Nilsson,Milton C. Weinstein |
| Citations | 19 |
| DOI | 10.1111/aos.12964 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/aos.12964 |
| OpenAlex ID | https://openalex.org/W2318485375 |
| PMID | 27061020 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Erin Hulbert](https://scholariq.org/researchers/erin-hulbert/)

## Paper journal

- [Acta Ophthalmologica](https://scholariq.org/journals/acta-ophthalmologica/)

## Paper primary topic

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

## Paper topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.